Oxford Science Enterprises Secures £175 Million NAV Financing
Deal News | May 07, 2025 | Rede Partners
Oxford Science Enterprises (OSE), an investment company founded in 2015 to support life sciences, healthtech, and deeptech sectors, has successfully signed a Net Asset Value (NAV) financing facility which provides up to £175 million. This installment is initially £100 million, with the remainder available upon increase, provided by Deutsche Bank and Goldman Sachs at favorable capital costs. The financing was finalized by March 2025 and represents a vital milestone in OSE’s ongoing growth strategy for cultivating transformative global companies. The funds will finance new investments and bolster OSE's current portfolio of over 100 companies, signifying an essential vote of confidence from global tier one investors. OSE is backed by reputable institutional shareholders including M&G, Lansdowne Partners, and Temasek, and has delivered over £334 million in returns with an average gross return of 7x during its operations.
Sectors
- Investment Management
- Life Sciences & Healthtech
- Financial Services
Geography
- United Kingdom – Oxford Science Enterprises is rooted in the UK, with a strategic partnership with the University of Oxford.
Industry
- Investment Management – The article deals with investment management activities as Oxford Science Enterprises is securing a large financing facility to boost its investment in life sciences, healthtech, and deeptech.
- Life Sciences & Healthtech – OSE focuses on investing and creating businesses in the life sciences and healthtech sectors, which comprises a part of its investment portfolio and strategic thrust.
- Financial Services – Entities such as Deutsche Bank and Goldman Sachs, involved in providing the NAV financing facility, belong to the financial services sector.
Financials
- 175 million – The total potential size of the NAV financing facility provided to Oxford Science Enterprises.
- 100 million – The initial size of the NAV financing facility committed to Oxford Science Enterprises.
- 334 million – The aggregate realized returns by OSE since its inception.
- 7x – The average gross return on exits by OSE's portfolio investments.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Oxford Science Enterprises | Target | Company | An independent investment company focused on scientific ventures in life sciences, healthtech, and deeptech, partnered with the University of Oxford. |
| Deutsche Bank | Lender | Company | A global banking institution providing a portion of the NAV financing for OSE. |
| Goldman Sachs | Lender | Company | An international investment bank providing part of the NAV financing for OSE. |
| Rede Partners | Advisor | Company | Acts as an advisor in facilitating the NAV financing for OSE. |
| University of Oxford | Strategic Partner | Organisation | Partnered with OSE to create and back science-based businesses. |
| M&G | Shareholder | Company | One of the global institutional investors supporting OSE. |
| Lansdowne Partners | Shareholder | Company | An institutional shareholder for OSE. |